Sanifit Therapeutics
Latest round
- Series D
Last raised
- Jun 2019
Total raised
- $109M
Investors
- 15
About Sanifit Therapeutics
L. is a clinical-stage biopharmaceutical company that treats vascular calcification disorders.L.A. is developing SNF472, which is a small molecule that is a selective and potent inhibitor of hydroxyapatite (HAP) crystallization that treats calciphylaxis or CUA (calcific uremic arteriolopathy) for patients undergoing dialysis. As of December 2021, SNF472 is under phase 3 clinical development.A.002 million in revenue in the fiscal year ended in December 2019.
Who invested in Sanifit Therapeutics
15 investors across 3 rounds
See all investors in Sanifit Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sanifit Therapeutics
Who invested in Sanifit Therapeutics?
Sanifit Therapeutics has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sanifit Therapeutics raised?
Sanifit Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Sanifit Therapeutics last raise money?
Sanifit Therapeutics's most recent round on record is a Series D, in Jun 2019.
What does Sanifit Therapeutics do?
Sanifit Therapeutics is a pharmaceuticals company.
Where is Sanifit Therapeutics headquartered?
Sanifit Therapeutics is headquartered in Palma, Spain.
Which VCs invest in companies like Sanifit Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Sanifit Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Sanifit Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.